SIGNIFOR is a prescription medication used in the treatment of Cushing's disease in adults who cannot undergo surgery or have not responded adequately to surgical interventions. It is also indicated for certain types of acromegaly, a disorder characterized by the excessive production of growth hormone. The active ingredient in SIGNIFOR is pasireotide, which works by mimicking the action of somatostatin, a natural inhibitor of growth hormone and other hormones. By binding to somatostatin receptors, pasireotide helps to reduce the levels of cortisol in Cushing's disease and growth hormone in acromegaly, thereby alleviating the symptoms associated with these conditions. SIGNIFOR is administered via injection and its use must be closely monitored by a healthcare professional due to potential side effects and the need for dosage adjustments based on the patient's response to therapy.